HealthCor Management L.P. trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH) by 41.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 103,100 shares of the healthcare conglomerate’s stock after selling 71,900 shares during the quarter. HealthCor Management L.P.’s holdings in UnitedHealth Group were worth $19,117,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Frontier Wealth Management LLC increased its position in UnitedHealth Group by 10.8% during the 2nd quarter. Frontier Wealth Management LLC now owns 6,712 shares of the healthcare conglomerate’s stock valued at $1,245,000 after purchasing an additional 652 shares during the period. HighVista Strategies LLC purchased a new position in UnitedHealth Group during the 2nd quarter valued at $575,000. Stifel Financial Corp increased its position in UnitedHealth Group by 2.4% during the 2nd quarter. Stifel Financial Corp now owns 1,375,824 shares of the healthcare conglomerate’s stock valued at $254,932,000 after purchasing an additional 32,287 shares during the period. Zacks Investment Management increased its position in UnitedHealth Group by 2.4% during the 2nd quarter. Zacks Investment Management now owns 145,361 shares of the healthcare conglomerate’s stock valued at $26,953,000 after purchasing an additional 3,447 shares during the period. Finally, Voya Investment Management LLC increased its position in UnitedHealth Group by 0.4% during the 2nd quarter. Voya Investment Management LLC now owns 3,169,861 shares of the healthcare conglomerate’s stock valued at $587,756,000 after purchasing an additional 11,126 shares during the period. 86.20% of the stock is currently owned by institutional investors.

Shares of UnitedHealth Group Incorporated (NYSE UNH) traded down $5.36 during trading on Tuesday, reaching $221.42. 5,591,400 shares of the company were exchanged, compared to its average volume of 3,118,647. The company has a market cap of $213,740.00, a PE ratio of 23.62, a price-to-earnings-growth ratio of 1.68 and a beta of 0.66. UnitedHealth Group Incorporated has a 52 week low of $156.09 and a 52 week high of $231.77. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.52.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.57 by $0.09. The company had revenue of $50.32 billion for the quarter, compared to analysts’ expectations of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. UnitedHealth Group’s revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.17 EPS. research analysts anticipate that UnitedHealth Group Incorporated will post 9.99 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Friday, December 1st will be paid a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a yield of 1.35%. The ex-dividend date of this dividend is Thursday, November 30th. UnitedHealth Group’s payout ratio is 34.09%.

A number of research analysts have issued reports on UNH shares. UBS reissued an “overweight” rating on shares of UnitedHealth Group in a research report on Thursday, August 24th. Zacks Investment Research downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, September 26th. Morgan Stanley upped their target price on shares of UnitedHealth Group from $215.00 to $235.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 18th. ValuEngine downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 5th. Finally, Leerink Swann reaffirmed a “buy” rating and issued a $240.00 target price (up from $225.00) on shares of UnitedHealth Group in a research report on Wednesday, October 18th. Three equities research analysts have rated the stock with a hold rating and twenty-three have assigned a buy rating to the company. UnitedHealth Group has an average rating of “Buy” and an average price target of $224.56.

In other UnitedHealth Group news, insider Larry C. Renfro sold 50,574 shares of the company’s stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the transaction, the insider now owns 195,625 shares in the company, valued at approximately $38,755,268.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction dated Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the transaction, the director now owns 61,137 shares in the company, valued at approximately $13,652,503.47. The disclosure for this sale can be found here. In the last quarter, insiders sold 57,606 shares of company stock worth $11,566,525. 0.89% of the stock is currently owned by company insiders.

TRADEMARK VIOLATION NOTICE: “HealthCor Management L.P. Has $19.12 Million Position in UnitedHealth Group Incorporated (UNH)” was published by Watch List News and is owned by of Watch List News. If you are reading this report on another domain, it was copied illegally and republished in violation of U.S. and international copyright law. The correct version of this report can be accessed at https://www.watchlistnews.com/healthcor-management-l-p-has-19-12-million-position-in-unitedhealth-group-incorporated-unh/1745906.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.